Delivery Order SPE2DR25D2005-SPE2DR26FF0N7
- Not listed
- The Defense Logistics Agency awarded a $3,576.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringe vaccine product on January 13, 2026, with completion targeted for January 14, 2026. This is an unrestricted, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a $9,451.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $6,947.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $1 billion and extending through December 2026. The vaccine product will be...
- On January 7, 2026, the Defense Logistics Agency awarded a $19,635 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The vaccine product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with a completion date...
- The Defense Logistics Agency awarded a $4,704.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes. The contract, with a completion date of November 25, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively made...
- The Defense Logistics Agency awarded a delivery order valued at $1,961.71 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. The order was competitively awarded without set-aside designation on January 7, 2026, with an ultimate completion date of January 8, 2026. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,009.25 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringe vaccine product on December 29, 2025, with a completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $1 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,936.91 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 12, 2025, with completion expected by December 15, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $27,961.22 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes. The contract, which is non-set-aside and competitively awarded, has a firm fixed price structure with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF0N7Delivery Order
The Defense Logistics Agency awarded a $8,645.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of TYPHIM VI 25 MCG/0.5 ML syringe vaccine product. This is a non-set-aside contract with an ultimate completion date of January 13, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement. The company has demonstrated capability to meet federal procurement requirements through open competition across its extensive portfolio of medical product deliveries with the Defense Logistics Agency and its Medical Supply Chain. The vaccine product supplied under this delivery order supports the Defense Health Agency and other government healthcare systems' immunization and preventive care programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 1/11/26 |